Your session is about to expire
← Back to Search
Very Low Energy Diet for Colorectal Cancer
Study Summary
This trial will study whether it is safe and possible for obese people with rectal cancer to lose weight before surgery, and if so, how much it would cost.
- Colorectal Cancer
- Obesity
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the intent of this medical experiment?
"The primary objective of this medical trial, to be assessed over a two-month window, is to reach the recruitment target (investigating feasibility). Other outcomes evaluated include cost comparison between Optifast 900 and other treatments during hospitalization; operative time for rectal cancer surgery in minutes; and postoperative adverse events such as surgical site infection (SSI), urinary tract infection (UTI), venous thromboembolism (VTE), pneumonia, acute kidney injury (AKI) etc. within 30 days after discharge."
Are there current openings for participants in this project?
"According to clinicaltrials.gov, this medical trial is actively seeking enrolment. It was posted on August 1st 2022 and has been revised as recently as the 26th of that same month."
How many participants are signed up for the study thus far?
"Affirmative. Clinicaltrials.gov suggests that this clinical trial, first publicized on August 1st 2022, is actively seeking recruits. 20 participants are sought from a single medical site."
Share this study with friends
Copy Link
Messenger